FDA approves Lannett’s new antidepressant

The Food and Drug Administration approved Lannett’s paroxetine extended release tablets.

Advertisement

Paroxetine tablets are intended to treat patients with depression, obsessive-compulsive disorder, anxiety disorders and post-traumatic stress disorder.

The tablets are a generic version of Paxil CR tablets created by Weston, Fla.-based Apotex Technologies.

The company has already begun shipping the medicine to customers.

More articles on supply chain:

Roche’s new HPV test earns FDA approval
6 latest FDA approvals
UPMC, IBM team up for better hospital supply chains

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.